Neutrophil–lymphocyte Ratio as an Early New Marker in AIV-H7N9-infected Patients: A Retrospective Study
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s206930
Full Text
Abstract
Available in
Date
July 1, 2019
Authors
Publisher
Informa UK Limited